Table 1.
Characteristic | Part A | Part B | |||
---|---|---|---|---|---|
Low dose (N=3) | Medium dose (N=3) | High dose (N=3) | Placebo (N=5) | ProTrans (N=10) | |
Age (years) | 24±3 | 24±1 | 27±1 | 31±9 | 31±4 |
Sex (no. female/no. male) | 0/3 | 0/3 | 0/3 | 3/2 | 4/6 |
Time since diagnosis (years) | 1.1±0.0 | 1.1±0.1 | 0.8±0.7 | 1.0±0.3 | 1.0±0.7 |
Weight (kg) | 75.1±10.4 | 80.2±8.1 | 75.7±2.7 | 67.5±12.6 | 73.9±9.3 |
BMI (kg/m2) | 22.5±2.5 | 24.2±2.5 | 23.7±1.2 | 23.5±2.2 | 24.2±2.9 |
Data are presented as median ± SD